Funders › NY › Daftuar Family Foundation › 2022
Grants paid by Daftuar Family Foundation, tax year 2022
EIN 47-4685449 · New York, NY · Form 990-PF, Part XV · NTEE G99
In tax year 2022, Daftuar Family Foundation (EIN 47-4685449) reported 8 grants paid totaling $1,504,646. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2022
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2022 | Greenwich Academy Inc Greenwich, CT | B | $600,000 | paid | CENTER FOR MATH EXCELLENCE AS PART OF LEAD THE WAY CAMPAIGN | 202303199349106900 |
| 2022 | Klinikum Ernst Von Bergmann Gemeinnutzige Gmbh Pottsdam | U | $156,474 | paid | RESEARCH PROPOSAL - "MORPHOLOGICAL MRI INVESTIGATION OF SUBCUTANEOUS ADIPOSE TISSUE IN LIPEDEMA PATIENTS" | 202303199349106900 |
| 2022 | University of Chicago Chicago, IL | U | $147,140 | paid | RESEARCH PROPOSAL - "ROLE OF LYMPHATIC CLOTTING AND NEUTROPHIL NETOSIS IN LIPEDEMA" | 202303199349106900 |
| 2022 | Texas a & M University College of Medicine Bryan, TX | U | $133,617 | paid | RESEARCH PROPOSAL - "IMPACT OF COMBINATION THERAPY ON LIPEDEMA PATIENT TISSUE STRESS" | 202303199349106900 |
| 2022 | Universite Libre de Bruxelles Bruxelles | U | $126,522 | approved, future | RESEARCH PROPOSAL - "BASIC TOOLBOX FOR LIPEDEMA SYNDROME ASSESSMENT" | 202303199349106900 |
| 2022 | The Regents of the University of California Los Angeles Los Angeles, CA | U | $125,000 | approved, future | RESEARCH PROPOSAL - "MESENCHYMAL PROGENITOR CELLS IN LIPEDEMA" | 202303199349106900 |
| 2022 | The Regents of the University of California Los Angeles Los Angeles, CA | U | $125,000 | paid | RESEARCH PROPOSAL - "MESENCHYMAL PROGENITOR CELLS IN LIPEDEMA" | 202303199349106900 |
| 2022 | Universite Libre de Bruxelles Bruxelles | U | $124,921 | paid | RESEARCH PROPOSAL - "BASIC TOOLBOX FOR LIPEDEMA SYNDROME ASSESSMENT" | 202303199349106900 |
| 2022 | University of North Texas Health Science Center Fort Worth, TX | C | $123,750 | approved, future | RESEARCH PROPOSAL - "ESTROGEN SIGNALING IN ADIPOSE TISSUE METABOLISM AND DEVELOPMENT OF LIPEDEMA" | 202303199349106900 |
| 2022 | University of North Texas Health Science Center Fort Worth, TX | C | $120,663 | paid | RESEARCH PROPOSAL - "ESTROGEN SIGNALING IN ADIPOSE TISSUE METABOLISM AND DEVELOPMENT OF LIPEDEMA" | 202303199349106900 |
| 2022 | Texas a & M University College of Medicine Bryan, TX | U | $116,382 | approved, future | RESEARCH PROPOSAL - "IMPACT OF COMBINATION THERAPY ON LIPEDEMA PATIENT TISSUE STRESS" | 202303199349106900 |
| 2022 | The Rector and Visitors of the University of Virginia Charlottesville, VA | C | $96,831 | paid | RESEARCH PROPOSAL | 202303199349106900 |
| 2022 | Klinikum Ernst Von Bergmann Gemeinnutzige Gmbh Pottsdam | U | $63,174 | approved, future | RESEARCH PROPOSAL - "MORPHOLOGICAL MRI INVESTIGATION OF SUBCUTANEOUS ADIPOSE TISSUE IN LIPEDEMA PATIENTS" | 202303199349106900 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990-PF e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.